Literature DB >> 32720213

The Multifaceted Roles of TAM Receptors during Viral Infection.

Zhao-Yang Wang1, Pei-Gang Wang2, Jing An3,4.   

Abstract

Tyro3, Axl, and Mertk (TAM) receptors play multiple roles in a myriad of physiological and pathological processes, varying from promoting the phagocytic clearance of apoptotic cells, sustaining the immune and inflammatory homeostasis, maintaining the blood-brain barrier (BBB) integrity and central nervous system (CNS) homeostasis, to mediating cancer malignancy and chemoresistance. Growth arrest-specific protein 6 (Gas6) and protein S (Pros1) are the two ligands that activate TAM receptors. Recently, TAM receptors have been reported to mediate cell entry and infection of multitudinous enveloped viruses in a manner called apoptotic mimicry. Moreover, TAM receptors are revitalized during viral entry and infection, which sequesters innate immune and inflammatory responses, facilitating viral replication and immune evasion. However, accumulating evidence have now proposed that TAM receptors are not required for the infection of these viruses in vivo. In addition, TAM receptors protect mice against the CNS infection of neuroinvasive viruses and relieve the brain lesions during encephalitis. These protective effects are achieved through maintaining BBB integrity, attenuating proinflammatory cytokine production, and promoting neural cell survival. TAM receptors also regulate the programmed cell death modes of virus-infected cells, which have profound impacts on the pathogenesis and outcome of infection. Here, we systematically review the functionalities and underlying mechanisms of TAM receptors and propose the potential application of TAM agonists to prevent severe viral encephalitis.

Entities:  

Keywords:  Axl; Infection; Mertk; Tyro3; Virus

Year:  2020        PMID: 32720213      PMCID: PMC7973326          DOI: 10.1007/s12250-020-00264-9

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  73 in total

1.  Axl receptor blockade ameliorates pulmonary pathology resulting from primary viral infection and viral exacerbation of asthma.

Authors:  Takehiko Shibata; David M Habiel; Ana L Coelho; Steven L Kunkel; Nicholas W Lukacs; Cory M Hogaboam
Journal:  J Immunol       Date:  2014-03-21       Impact factor: 5.422

2.  Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase Cδ, and p38 mitogen-activated protein kinase (MAPK).

Authors:  Edward Thorp; Tomas Vaisar; Manikandan Subramanian; Lauren Mautner; Carl Blobel; Ira Tabas
Journal:  J Biol Chem       Date:  2011-08-02       Impact factor: 5.157

3.  Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry.

Authors:  Masayuki Shimojima; Ute Ströher; Hideki Ebihara; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

4.  Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway.

Authors:  K O'Donnell; I C Harkes; L Dougherty; I P Wicks
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

5.  Zika virus cell tropism in the developing human brain and inhibition by azithromycin.

Authors:  Hanna Retallack; Elizabeth Di Lullo; Carolina Arias; Kristeene A Knopp; Matthew T Laurie; Carmen Sandoval-Espinosa; Walter R Mancia Leon; Robert Krencik; Erik M Ullian; Julien Spatazza; Alex A Pollen; Caleigh Mandel-Brehm; Tomasz J Nowakowski; Arnold R Kriegstein; Joseph L DeRisi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-29       Impact factor: 11.205

6.  Intracellular signaling pathways involved in Gas6-Axl-mediated survival of endothelial cells.

Authors:  Ines Hasanbasic; Jessica Cuerquis; Brian Varnum; Mark D Blostein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-05-06       Impact factor: 4.733

7.  Zika Virus Infection in Mice Causes Panuveitis with Shedding of Virus in Tears.

Authors:  Jonathan J Miner; Abdoulaye Sene; Justin M Richner; Amber M Smith; Andrea Santeford; Norimitsu Ban; James Weger-Lucarelli; Francesca Manzella; Claudia Rückert; Jennifer Govero; Kevin K Noguchi; Gregory D Ebel; Michael S Diamond; Rajendra S Apte
Journal:  Cell Rep       Date:  2016-09-06       Impact factor: 9.423

8.  Lassa Virus Cell Entry via Dystroglycan Involves an Unusual Pathway of Macropinocytosis.

Authors:  Joel Oppliger; Giulia Torriani; Antonio Herrador; Stefan Kunz
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

Review 9.  The Emerging Role of TYRO3 as a Therapeutic Target in Cancer.

Authors:  Sherri K Smart; Eleana Vasileiadi; Xiaodong Wang; Deborah DeRyckere; Douglas K Graham
Journal:  Cancers (Basel)       Date:  2018-11-29       Impact factor: 6.639

10.  The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer.

Authors:  Diana J Uribe; Edward K Mandell; Adam Watson; Jesse D Martinez; Jonathan A Leighton; Sourav Ghosh; Carla V Rothlin
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

View more
  3 in total

Review 1.  Molecular Mechanisms in the Genesis of Seizures and Epilepsy Associated With Viral Infection.

Authors:  Wolfgang Löscher; Charles L Howe
Journal:  Front Mol Neurosci       Date:  2022-05-09       Impact factor: 6.261

2.  TIM-1 Augments Cellular Entry of Ebola Virus Species and Mutants, Which Is Blocked by Recombinant TIM-1 Protein.

Authors:  Min Zhang; Xinwei Wang; Linhan Hu; Yuting Zhang; Hang Zheng; Haiyan Wu; Jing Wang; Longlong Luo; He Xiao; Chunxia Qiao; Xinying Li; Weijin Huang; Youchun Wang; Jiannan Feng; Guojiang Chen
Journal:  Microbiol Spectr       Date:  2022-04-06

Review 3.  Role of Vitamin K-Dependent Factors Protein S and GAS6 and TAM Receptors in SARS-CoV-2 Infection and COVID-19-Associated Immunothrombosis.

Authors:  Anna Tutusaus; Montserrat Marí; José T Ortiz-Pérez; Gerry A F Nicolaes; Albert Morales; Pablo García de Frutos
Journal:  Cells       Date:  2020-09-28       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.